Intensity Modulated Proton Therapy for Hepatocellular Carcinoma: Initial Clinical Experience

Intensity Modulated Proton Therapy for Hepatocellular Carcinoma: Initial Clinical Experience

Purpose: Our purpose was to assess the safety and efficacy of intensity modulated proton therapy (IMPT) for the treatment of hepatocellular carcinoma (HCC). Methods and Materials: A retrospective review was conducted on all patients who were treated with IMPT for HCC with curative intent from June 2...

Full description

Bibliographic Details
Main Authors: Ronik S. Bhangoo, MD, Trey C. Mullikin, MD, Jonathan B. Ashman, MD, PhD, Tiffany W. Cheng, BA, Michael A. Golafshar, MS, Todd A. DeWees, PhD, Jedediah E. Johnson, PhD, Satomi Shiraishi, PhD, Wei Liu, PhD, Yanle Hu, PhD, Kenneth W. Merrell, MD, Michael G. Haddock, MD, Sunil Krishnan, MD, William G. Rule, MD, Terence T. Sio, MD, Christopher L. Hallemeier, MD
Format: Article
Language:English
Published: Elsevier 2021-07-01
Series:Advances in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2452109421000336

Internet

http://www.sciencedirect.com/science/article/pii/S2452109421000336

Similar Items